Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease-Reference-Cited by-同舟云学术

Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease

Published:2018-04 Issue:2 Volume:55 Page:87-93
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Guilcher Gregory M.T.,Truong Tony H.,Saraf Santosh L.,Joseph Jacinth J.,Rondelli Damiano,Hsieh Matthew M.

Funder

NHLBI

Publisher

Elsevier BV

Subject

Hematology

Reference69 articles.

1. Bone marrow transplantation in the treatment of sickle cell anemia;Johnson;Am J Pediatr Hematol Oncol.,1985

2. Bone-marrow transplantation in a patient with sickle-cell anemia;Johnson;N Engl J Med,1984

3. Perspective: we need a global solution;Odame;Nature.,2014

4. Bone marrow transplantation in sickle cell anaemia;Vermylen;Arch Dis Child,1991

5. Bone marrow transplantation for sickle cell disease. The European experience;Vermylen;Am J Pediatr Hematol Oncol.,1994

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fostering a healthier generation of children with sickle cell disease through advancements in care;Pediatric Research;2024-09-13

2. Favorable outcome of non‐myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients;American Journal of Hematology;2024-03-15

3. Curative Therapies for Sickle Cell Disease;Pediatric Annals;2024-02

4. An update review of new therapies in sickle cell disease: the prospects for drug combinations;Expert Opinion on Pharmacotherapy;2024-01-22

5. Novel frontiers in gene therapy: In vivo gene editing;HemaSphere;2024-01